Acute Kidney Injury News

An exploration of a registry of patients undergoing continuous kidney replacement therapy revealed fluid management is a main indicator that a patient will initiate the therapy, according to data published in Kidney Medicine.

COVID-19 infection has resulted in AKI in about 3% to 15% of cases in the United States, and severe infection in about 15% to 50% of cases.

AUSTIN, Texas — Patients with AKI self-reported a high level of physical and emotional burdens, revealing fatigue to be one of the most common symptoms, according to a presenter at the National Kidney Foundation Spring Clinical Meetings.

Patients who were obese, overweight or underweight were at an increased risk for AKI, compared with patients who had a normal BMI, according to data published in the Journal of Renal Nutrition.

The FDA granted CardioRenal Systems breakthrough device designation for its RenalGuard Therapy, according to a press release.

The shrunken pore syndrome phenotype of renal dysfunction after PCI may be a stronger predictor of contrast-induced acute kidney injury compared with chronic kidney disease, researchers reported.

Risk of adverse kidney outcomes after angiography with IV fluid volumes of at least 1L administered in a period of 6 hours was similar to that found for higher volumes with fluid administration durations longer than 6 hours, research shows.

ORLANDO — An increase in discontinuation of medications that could have a positive impact on kidney outcomes resulted from a medication-targeted AKI alert, according to a presenter at ASN Kidney Week.

Since 2000, the Acute Disease Quality Initiative has met to discuss kidney disease in adults, but in 2021, Rajit K. Basu, MD, coordinated the first meeting to focus solely on pediatric AKI critical care in nephrology.

Patients with hepatorenal syndrome type 1 and advanced acute-on-chronic liver failure had significantly greater incidence of respiratory failure and 90-day mortality when treated with terlipressin vs. placebo, according to research.